UPDATE: Bank Of America Reiterates On Vital Therapies On Improved Outlook

By: via Benzinga
In a report published Friday, Bank of America analyst Steve Byrne reiterated a Buy rating on Vital Therapies (NASDAQ: VTL), and raised ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.